This article has been updated with information and comments from Foundation Medicine's earning call.
NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that its fourth quarter revenues climbed 11 percent, driven by strong growth from its biopharmaceutical business.